IP Library Granted Patent US 11,904,289
Granted Patent B2
US 11,904,289 · App. 17/131,420 · Granted Feb 20, 2024

Systems, methods and devices for producing, manufacturing and control of radiopharmaceuticals

Inventors: Dennis Eshima (Phoenix, AZ); Mehmet Husnu (Phoenix, AZ); James Stone (Alpharetta, GA); Derrick Alcaide (Los Angeles, CA); Joseph E. Zambanini (Delaware, OH); Thomas A. Klausing (Powell, OH); Chad E. Bouton (Powell, OH); Henry Padgett (Dublin, OH); Brian C. Kelley (Pataskala, OH); Scott N. Danhof (Plain City, OH); David A. Holley (Lancaster, OH); Jeffrey T. Stroup (Upper Arlington, OH); James B. Gleeson (Westerville, OH); Eric Hassenpflug (Westerville, OH); James A. Prescott (Columbus, OH); Herman Benecke (Columbus, OH); Daniel B. Garbark (Blacklick, OH)
Assignee: Cardinal Health 414, LLC
B01J19/0006A61K51/0491B01J19/004B65B1/00B65B3/003G21G1/10A61J3/002B01J19/0046B01J2219/00049B01J2219/0072B01J2219/00351B01J2219/00355B01J2219/00585B01J2219/00693B01J2219/00702B01J2219/00722B01J2219/00759G21G2001/0015
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,904,289
App. No.
17/131,420
Granted
Feb 20, 2024
Kind
B2
Abstract

Systems, methods, and devices for generating radionuclides for use in production of radiopharmaceuticals; synthesizing the radionuclides generated and removing any unwanted products; measuring the quantity and activity level of the synthesized radionuclides; distributively delivering the radionuclides in appropriate quantities to modular cassette synthesis units in a modular cassette subsystem for contemporaneous/parallel production of radiopharmaceutical output and that allow reuse and/or quick, safe, and disposable replacement of portions of the subsystem; delivering non-radionuclide components to the modular cassette synthesis units as part of production of radiopharmaceutical output; measuring the quantity and activity level of each stream of radiopharmaceutical output; purifying the radiopharmaceutical output; dispensing individual doses in sterile vial(s); automatically producing labeling and dose related information; performing automated quality control on extracted samples of produced radiopharmaceutical output; and providing software and hardware controls for overall and sub-portion operation for optional remote data collection, communication, and/or control.

Claims (25)

1. A radiopharmaceutical production system comprising:

a cyclotron;

a synthesis unit operatively connected to the cyclotron and to a reagent pack, the synthesis unit comprising at least one modular, disposable cassette unit for receiving a radionuclide from the cyclotron and one or more pharmaceutical reagents from the reagent pack;

a vial filler operatively connected to the synthesis unit for dispensing a radiopharmaceutical produced by the synthesis unit into a vial;

a quality control unit operatively connected to the synthesis unit for performing automated quality control on a sample of at least one dose of the radiopharmaceutical; and

a control platform operatively connected to at least one of the synthesis unit and the quality control unit for receiving therefrom and for associating a unique identifier with each dose of the radiopharmaceutical synthesized by the system.

2. The radiopharmaceutical production system according to claim 1 , further comprising a purifying component to purify the at least one dose of the radiopharmaceutical prior to the at least one dose of the radiopharmaceutical being received in the vial.

3. The radiopharmaceutical production system according to claim 2 , wherein the purifying component comprises a solid phase extraction component.

4. The radiopharmaceutical production system according to claim 2 , wherein the purifying component comprises an HPLC component.

5. The radiopharmaceutical production system according to claim 2 , wherein at least a portion of the purifying component is disposable.

6. The radiopharmaceutical production system according to claim 1 , further comprising at least one reagent pack, wherein the at least one reagent pack is attachable to the synthesis unit.

7. The radiopharmaceutical production system according to claim 6 , wherein the at least one reagent pack is disposable.

8. The radiopharmaceutical production system according to claim 6 , wherein the at least one reagent pack is detachable from the at least one cassette unit.

9. The radiopharmaceutical production system according to claim 6 , wherein the at least one reagent pack is receivable for one or more disposable reagent capsules.

10. The radiopharmaceutical production system according to claim 1 , wherein the radionuclide comprises F-18.

11. The radiopharmaceutical production system according to claim 1 , comprising at least two modular, disposable cassette units.

12. The radiopharmaceutical production system according to claim 11 , further comprising a splitter operatively connected to the cyclotron for routing the radionuclide to each of the at least two cassette units.

13. The radiopharmaceutical production system according to claim 12 , wherein the splitter comprises a pump to dispose a predetermined amount of the radionuclide to each of the at least two cassette units.

14. The radiopharmaceutical production system according to claim 1 , further comprising a check valve to deliver a metered amount of a fluid containing O-18 atoms to a target cell irradiated by a proton beam, wherein the proton beam converts the O-18 to F-18.

15. The radiopharmaceutical production system according to claim 1 , further comprising a communication connection to a dispensing pharmacy.

16. The radiopharmaceutical production system according to claim 1 , wherein the vial filler comprises a sensor to measure at least one of an activity level and a volume of the at least one dose of the radiopharmaceutical received in the vial.

17. The radiopharmaceutical production system according to claim 16 , wherein the sensor comprises a cadmium zinc telluride element.

18. The radiopharmaceutical production system according to claim 1 , comprising six modular, disposable cassette units.

19. The radiopharmaceutical production system according to claim 1 , wherein the at least one cassette unit comprises a reaction vessel and at least one of a quaternary methylammonium cartridge, heating provisions, a mixing chamber, a neutralizing chamber, a final production collection chamber, and a solid phase exchange cartridge.

20. The radiopharmaceutical production system according to claim 1 , wherein the quality control unit is operatively connected to the synthesis unit to assess the sample of the at least one dose of the radiopharmaceutical for particle and color content, filter membrane integrity, pH value, residual solvent volume, Kryptofix concentration, bacterial endotoxins concentration, radionuclidic identify, radionuclidic purity, radiochemical identity, radiochemical purity, sterility, or a combination thereof.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2021
From: BATTELLE MEMORIAL INSTITUTE
To: CARDINAL HEALTH 414, LLC
Reel/Frame 057548/0774 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2021
From: ESHIMA, DENNIS; HUSNU, MEHMET; STONE, JAMES EDDIE; PADGETT, HENRY CLIFTON; ALCAIDE, DERRICK MICHAEL
To: CARDINAL HEALTH 414, LLC
Reel/Frame 057555/0242 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2021
From: BOUTON, CHAD EDWARD; STROUP, JEFFREY TAYLOR; KELLEY, BRIAN CHARLES; HOLLEY, DAVID ARTHUR; KLAUSING, THOMAS ALAN; ZAMBANINI, JOSEPH EDWARD; GARBARK, DANIEL BRENT; PRESCOTT, JAMES ALAN; HASSENPFLUG, ERIC GUSTIN; DANHOF, SCOTT NICHOLAS; GLEESON, JAMES B.; BENECKE, HERMAN PAUL
To: BATTELLE MEMORIAL INSTITUTE
Reel/Frame 057555/0299 →
Continuity (20)
Continuation 14871287 · Sep 30, 2015
Continuation In Part 14635343 · Mar 2, 2015
Continuation 13550026 · Jul 16, 2012
Continuation In Part 13550425 · Jul 16, 2012
Provisional Application 61553029 · Oct 28, 2011
Provisional Application 61508373 · Jul 15, 2011
Provisional Application 61508359 · Jul 15, 2011
Provisional Application 61508394 · Jul 15, 2011
Provisional Application 61508402 · Jul 15, 2011
Provisional Application 61508349 · Jul 15, 2011
Provisional Application 61508409 · Jul 15, 2011
Provisional Application 61508294 · Jul 15, 2011
Provisional Application 61508382 · Jul 15, 2011
Provisional Application 61508464 · Jul 15, 2011
Provisional Application 61508353 · Jul 15, 2011
Provisional Application 61508374 · Jul 15, 2011
Provisional Application 61508383 · Jul 15, 2011
Provisional Application 61508367 · Jul 15, 2011
Provisional Application 61508408 · Jul 15, 2011
Related Publication 20210187467A1 · Jun 24, 2021